Purpose: To evaluate the antimicrobial effectiveness of a liposomal ozonised-oil solution used as a home therapy in patients undergoing cataract surgery. Antimicrobial efficacy was evaluated as the reduction in the bacterial load of the most common bacteria isolated from endophthalmitis cases. Setting: Twenty Italian experimental centres of the ELOOM (Effectiveness of Liposomal Ozonised-oil on Ocular Microbial flora before cataract surgery) study group. Design: An interventional, non-randomised, paired-eye designed, Phase 4 clinical study METHODS:: A total of 174 patients undergoing cataract surgery were divided into two groups: the study group (174 eyes) underwent surgery and received an isotonic ophthalmic solution of 0.5% ozonised oil in liposomes plus hypromellose treatment (2 drops 4 times/day), and the control group (174 contralateral eyes) was treated with saline solution. The treatment lasted for 3 days. Subconjunctival swabs were taken from both eyes of each patient at T0 (the day before starting the treatment, 4 days before surgery) and at T4 (after 3 days of treatment, 10 min before surgery) and sent to the laboratory within 24 h of collection for microbiological analysis. Results: Thirty percent of swabs taken at T0 were sterile. Contaminated swabs had a high prevalence of coagulase-negative staphylococci, including Staphylococcus epidermidis, and more than 60 different bacterial species were isolated. A significant reduction in microbial load was observed after treatment (>90% of the samples). The microbial load in the control group remained unchanged. Conclusions: Liposomal ozonised oil reduced the microbial burden after topical administration in a large study population.
Effectiveness of liposomal ozonised oil in reducing ocular microbial flora in patients undergoing cataract surgery / Spadea, L.; Zanotto, E.; Cavallo, R.; Campagna, G.; Giannico, M. I.; Costagliola, C.. - In: JOURNAL OF CATARACT AND REFRACTIVE SURGERY. - ISSN 0886-3350. - 47:12(2021), pp. 1548-1555. [10.1097/j.jcrs.0000000000000672]
Effectiveness of liposomal ozonised oil in reducing ocular microbial flora in patients undergoing cataract surgery
Spadea L.
Primo
;Zanotto E.Secondo
;Campagna G.;Giannico M. I.Penultimo
;Costagliola C.Ultimo
2021
Abstract
Purpose: To evaluate the antimicrobial effectiveness of a liposomal ozonised-oil solution used as a home therapy in patients undergoing cataract surgery. Antimicrobial efficacy was evaluated as the reduction in the bacterial load of the most common bacteria isolated from endophthalmitis cases. Setting: Twenty Italian experimental centres of the ELOOM (Effectiveness of Liposomal Ozonised-oil on Ocular Microbial flora before cataract surgery) study group. Design: An interventional, non-randomised, paired-eye designed, Phase 4 clinical study METHODS:: A total of 174 patients undergoing cataract surgery were divided into two groups: the study group (174 eyes) underwent surgery and received an isotonic ophthalmic solution of 0.5% ozonised oil in liposomes plus hypromellose treatment (2 drops 4 times/day), and the control group (174 contralateral eyes) was treated with saline solution. The treatment lasted for 3 days. Subconjunctival swabs were taken from both eyes of each patient at T0 (the day before starting the treatment, 4 days before surgery) and at T4 (after 3 days of treatment, 10 min before surgery) and sent to the laboratory within 24 h of collection for microbiological analysis. Results: Thirty percent of swabs taken at T0 were sterile. Contaminated swabs had a high prevalence of coagulase-negative staphylococci, including Staphylococcus epidermidis, and more than 60 different bacterial species were isolated. A significant reduction in microbial load was observed after treatment (>90% of the samples). The microbial load in the control group remained unchanged. Conclusions: Liposomal ozonised oil reduced the microbial burden after topical administration in a large study population.File | Dimensione | Formato | |
---|---|---|---|
Spadea_postprint_Effectiveness of Liposomal_2021.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Creative commons
Dimensione
407.14 kB
Formato
Adobe PDF
|
407.14 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.